Publication date: Jul 09, 2025
It is a carefully manufactured investigational new drug (IND) composed of natural cannabis extracts and formulated in pharmaceutical-grade capsules under FDA standards. “It shows the FDA recognizes the urgent unmet medical need and our serious commitment to bringing a therapeutic option to these patients. ” “This is about providing real medicine to real patients-starting with one of the most vulnerable populations: those suffering from Huntington’s Disease. “We’re not interested in chasing the wellness trends or the recreational market,” says Boise. “Orphan status is not just a regulatory milestone-it’s a lifeline,” explains Boise. MMJ-001 is not a dietary supplement. It is not sold in dispensaries.
| Concepts | Keywords |
|---|---|
| Biopharmaceutical | Boise |
| Cannabis | Cannabis |
| Ceo | Capsules |
| Devastating | Drug |
| July | Fda |
| Grade | |
| Huntington | |
| International | |
| Mmj | |
| Natural | |
| Neurological | |
| Orphan | |
| Pharmaceutical | |
| Plant | |
| Status |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | chorea |
| disease | MESH | Huntington’s Disease |
| drug | DRUGBANK | Cannabidiol |
| drug | DRUGBANK | Gelatin |
| disease | MESH | Neurological Disorder |
| drug | DRUGBANK | Medical Cannabis |
Original Article
(Visited 4 times, 1 visits today)